|
ATTACHMENT C8-a.
Overview of NASS Data Elements Used for Success Rates Calculations, and Publication Plan
|
|||||
|
|
Variable status 2 (add, drop, modify, unchanged) |
Used in Success Rates Calculations 3 |
‘Other Significant Factors’ (FCSRCA) Affecting Success Rates 3 |
Dissemination and Publication Plan |
|
|
|
|
|
|
|
|
1 |
Date of cycle reporting |
Add |
X |
|
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
2 |
NASS Patient ID |
Unchanged |
X |
|
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
3 |
Patient Optional Identifiers |
Modify |
|
|
Optional Field for Clinic Use |
|
4 |
Date of Birth (Patient) |
Unchanged |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
5 |
Sex of patient seeking ART |
Add |
|
X |
Supplemental Publications |
|
6 |
Cycle start date |
Modify |
X |
|
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
7 |
Patient US Resident |
Modify |
|
X |
ART Surveillance Summary Supplemental Publications |
|
8 |
Patient Country of Residence (if not United States) |
Unchanged |
|
X |
ART Surveillance Summary Supplemental Publications |
|
9 |
Patient State of Residence |
Modify |
|
X |
ART Surveillance Summary Supplemental Publications |
|
10 |
Patient city of residence |
Modify |
|
X |
ART Surveillance Summary Supplemental Publications |
|
11 |
Patient Zip Code of residence |
Modify |
|
X |
ART Surveillance Summary Supplemental Publications |
|
12 |
Intended cycle type |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
13 |
Embryo or oocyte banking type |
Modify |
X |
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
14 |
Intended duration of oocyte banking |
Add |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation Supplemental Publications |
|
15 |
Intended duration of embryo banking |
Add |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation Supplemental Publications |
|
16 |
Intended embryo source |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
17 |
Intended Oocyte Source and state |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
18 |
Intended Sperm Source (Partner, Donor, Mixed) |
Modify |
|
X |
ART National Summary Report Supplemental Publications |
|
19 |
Intended pregnancy carrier |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Supplemental Publications |
|
20 |
Cycle type |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation Supplemental Publications |
|
21 |
Embryo source |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation Supplemental Publications |
|
22 |
Oocyte Source and state |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation Supplemental Publications |
|
23 |
Reason for ART |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation Supplemental Publications |
|
24 |
Female Patient Height |
Unchanged |
|
X |
Supplemental Publications |
|
25 |
Female Patient Weight at the start of this cycle |
Unchanged |
|
X |
Supplemental Publications |
|
26 |
History of cigarette smoking |
Modify |
|
X |
Supplemental Publications |
|
27 |
Prior pregnancy |
Add |
|
X |
ART National Summary Report Supplemental Publications |
|
28 |
Months attempting pregnancy (if couple is not surgically sterile) |
Add |
|
X |
Supplemental Publications |
|
29 |
Female Patient Gravidity |
Modify |
|
X |
ART National Summary Report Supplemental Publications |
|
30 |
Prior Full-Term Births |
Unchanged |
|
X |
ART National Summary Report Supplemental Publications |
|
31 |
Prior Preterm Births |
Unchanged |
|
X |
ART National Summary Report Supplemental Publications |
|
32 |
Number of Prior Stillbirths |
Add |
|
X |
ART National Summary Report Supplemental Publications |
|
33 |
Prior Spontaneous Abortions (miscarriage) |
Unchanged |
|
X |
ART National Summary Report Supplemental Publications |
|
34 |
Prior ectopic pregnancies |
Add |
|
X |
ART National Summary Report Supplemental Publications |
|
35 |
Prior stimulations for ART |
Modify |
|
X |
ART National Summary Report Supplemental Publications |
|
36 |
Prior Frozen ART Cycles |
Unchanged |
|
X |
ART National Summary Report Supplemental Publications |
|
37 |
Prior ART cycles resulted in pregnancy |
Add |
|
X |
ART National Summary Report Supplemental Publications |
|
38 |
Female Patient Maximum Follicle Stimulating Hormone (FSH) Level |
Modify |
|
X |
Supplemental Publications |
|
39 |
Anti-Mullerian Hormone (AMH) level (ng/mL) |
Add |
|
X |
Supplemental Publications |
|
40 |
Date of Birth (Oocyte source) |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
41 |
Oocyte source ethnicity |
Modify |
|
X |
Supplemental Publications |
|
42 |
Oocyte source race |
Modify |
|
X |
Supplemental Publications |
|
43 |
Pregnancy carrier |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Supplemental Publications |
|
44 |
Pregnancy carrier date of birth |
Modify |
|
X |
Supplemental Publications |
|
45 |
Pregnancy carrier Ethnicity |
Modify |
|
X |
Supplemental Publications |
|
46 |
Pregnancy carrier Race |
Modify |
|
X |
Supplemental Publications |
|
47 |
Sperm source |
Modify |
|
X |
ART National Summary Report Supplemental Publications |
|
48 |
Sperm source date of birth |
Add |
|
X |
Supplemental Publications |
|
49 |
Sperm source Ethnicity |
Add |
|
X |
Supplemental Publications |
|
50 |
Sperm source Race |
Add |
|
X |
Supplemental Publications |
|
51 |
Medications given to stimulate follicular development |
Unchanged |
|
X |
ART Clinic Success Rates Report Supplemental Publications |
|
52 |
Oral medications given |
Modify |
|
X |
Supplemental Publications |
|
53 |
Medications containing FSH |
Modify |
|
X |
Supplemental Publications |
|
54 |
Medications with LH/HCG activity |
Add |
|
X |
Supplemental Publications |
|
55 |
GnRH Protocol |
Modify |
|
X |
Supplemental Publications |
|
56 |
Cycle cancelled before retrieval |
Unchanged |
X |
|
ART Clinic Success Rates Report ART National Summary Report Data Validation Supplemental Publications |
|
57 |
Date of Cancellation |
Unchanged |
|
X |
Supplemental Publications |
|
58 |
Reason for Cancel |
Modify |
|
X |
ART National Summary Report Supplemental Publications |
|
59 |
Date of Oocyte Retrieval |
Unchanged |
X |
|
ART Clinic Success Rates Report ART National Summary Report Supplemental Publications |
|
60 |
Number of Patient Oocytes Retrieved |
Unchanged |
|
X |
Supplemental Publications |
|
61 |
Number of Donor Oocytes Retrieved |
Unchanged |
|
X |
Supplemental Publications |
|
62 |
Use of retrieved oocytes |
Modify |
|
X |
ART Clinic Success Rates Report Supplemental Publications |
|
63 |
Number of Fresh Oocytes Cryopreserved |
Unchanged |
|
X |
ART National Summary Report Supplemental Publications |
|
64 |
Complications of stimulation or retrieval |
Add |
|
X |
Supplemental Publications |
|
65 |
Type of complications related to ovarian stimulation or oocyte retrieval |
Modify |
|
X |
Supplemental Publications |
|
66 |
Hospitalization for Complication |
Modify |
|
X |
Supplemental Publications |
|
67 |
Sperm State |
Add |
|
X |
Supplemental Publications |
|
68 |
Sperm Collection Method (Ejaculation, Epididymal Aspiration, Testicular Biopsy, Electroejaculation, Retrograde Ejaculation) |
Modify |
|
X |
Supplemental Publications |
|
69 |
Use of Intracytoplasmic Sperm Injection |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Supplemental Publications |
|
70 |
Indication for ICSI |
Add |
|
X |
ART National Summary Report Supplemental Publications |
|
71 |
In vitro maturation used? |
Modify |
|
X |
ART Clinic Success Rates Report ART National Summary Report Supplemental Publications |
|
72 |
PGD or PGS performed on embryos |
Unchanged |
|
X |
ART Clinic Success Rates Report ART National Summary Report Supplemental Publications |
|
73 |
Total 2PN |
Add |
|
X |
Supplemental Publications |
|
74 |
Pre-implantation genetic diagnosis (PGD) or screening (PGS) reason |
Modify |
|
X |
Supplemental Publications |
|
75 |
Pre-implantation genetic diagnosis or screening technique |
Add |
|
X |
Supplemental Publications |
|
76 |
Use of Assisted Hatching |
Modify |
|
X |
ART National Summary Report Supplemental Publications |
|
77 |
Research cycle |
Add |
|
X |
ART Clinic Success Rates Report ART National Summary Report ART Surveillance Summary Supplemental Publications |
|
78 |
Study type |
Modify |
|
X |
ART Clinic Success Rates Report Supplemental Publications |
|
79 |
Transfer attempted |
Modify |
X |
|
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
80 |
Reason transfer not attempted |
Add |
|
X |
ART National Summary Report Supplemental Publications |
|
81 |
Transfer Date |
Unchanged |
|
X |
ART Clinic Success Rates Report ART National Summary Report Supplemental Publications |
|
82 |
Endometrial Thickness |
Add |
|
X |
Supplemental Publications |
|
83 |
Number of Fresh Embryos Transferred to Uterus |
Unchanged |
X |
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
84 |
Elective single embryo transfer (fresh transfers) |
Unchanged |
X |
X |
ART Clinic Success Rates Report ART National Summary Report ART Surveillance Summary Supplemental Publications |
|
85 |
Quality of embryo (fresh transfers) |
Add |
|
X |
ART National Summary Report Supplemental Publications |
|
86 |
Number of Fresh Embryos Cryopreserved |
Unchanged |
|
X |
ART National Summary Report Supplemental Publications |
|
87 |
Number of Thawed Embryos Transferred to Uterus |
Unchanged |
X |
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
88 |
Elective single embryo transfer (frozen transfers) |
Modify |
X |
X |
ART Clinic Success Rates Report ART National Summary Report ART Surveillance Summary Supplemental Publications |
|
89 |
Quality of embryo (frozen transfers) |
Add |
|
X |
ART National Summary Report Supplemental Publications |
|
90 |
Date of oocyte retrieval (thawed embryos) |
Add |
X |
|
ART Clinic Success Rates Report ART National Summary Report Supplemental Publications |
|
91 |
Number of Thawed Embryos Cryopreserved (re-frozen) |
Unchanged |
|
X |
ART National Summary Report Supplemental Publications |
|
92 |
Number of Oocytes or embryos Transferred to Fallopian Tubes |
Modify |
X |
X |
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
93 |
Outcome of Treatment (Not Pregnant, Biochemical Pregnancy, Ectopic Pregnancy, Clinical Intrauterine Gestation, Heterotopic Pregnancy, Unknown) |
Unchanged |
X |
|
ART Clinic Success Rates Report ART National Summary Report Data Validation Supplemental Publications |
|
94 |
Maximum Number of Fetal Hearts Observed on Ultrasound |
Modify |
X |
|
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
95 |
Ultrasound Date |
Modify |
|
X |
Supplemental Publications |
|
96 |
Monochorionicity |
Add |
|
X |
Supplemental Publications |
|
97 |
Outcome of Pregnancy (Live birth, Stillbirth, Spontaneous Abortion, Induced Abortion, Maternal Death Prior to Birth, Unknown) |
Unchanged |
X |
|
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
98 |
Date of Pregnancy Outcome |
Unchanged |
X |
|
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
99 |
Method of delivery |
Add |
|
X |
Supplemental Publications |
|
100 |
Source of information on pregnancy outcome |
Unchanged |
|
X |
Supplemental Publications |
|
101 |
Number of Infants Born |
Unchanged |
X |
|
ART Clinic Success Rates Report ART National Summary Report Data Validation ART Surveillance Summary Supplemental Publications |
|
102 |
Birth outcome for Each Infant |
Unchanged |
X |
|
ART Clinic Success Rates Report ART National Summary Report ART Surveillance Summary Supplemental Publications |
|
103 |
Gender for each liveborn or stillborn infant |
Unchanged |
|
X |
Supplemental Publications |
|
104 |
Birth weight for Each Live-born and Stillborn Infant |
Unchanged |
X |
|
ART Clinic Success Rates Report ART National Summary Report ART Surveillance Summary Supplemental Publications |
|
105 |
Birth Defects Diagnosed for Each Live-born and Stillborn Infant (Genetic Defect/Chromosomal Abnormality, Cleft Lip or Palate, Neural Tube Defect, Cardiac Defect, Limb Defect, Other Defect) |
Modify |
|
X |
Supplemental Publications |
|
106 |
Lab Upper Normal Limit for that FSH level |
Drop |
|
|
|
|
107 |
Lab upper normal FSH unknown |
Drop |
|
|
|
|
108 |
FSH Unknown |
Drop |
|
|
|
|
109 |
Patient Maximum Estradiol Level |
Drop |
|
|
|
|
110 |
Lab Upper Normal Limit for that Estradiol Level |
Drop |
|
|
|
|
111 |
Number of Fresh Embryos Transferred to Fallopian Tubes |
Drop |
|
|
|
|
112 |
Number of Thawed Embryos Transferred to Fallopian Tubes |
Drop |
|
|
|
|
113 |
Surgical Sterilization—Patient or Partner |
Drop |
|
|
|
|
114 |
Was an Ultrasound Performed? |
Drop |
|
|
|
|
115 |
Donor medicated to stimulate follicular development |
Drop |
|
|
|
|
116 |
Donor medications containing clomiphene |
Drop |
|
|
|
|
117 |
Donor clomiphene dosage |
Drop |
|
|
|
|
118 |
Donor medications containing FSH |
Drop |
|
|
|
|
119 |
Donor GnRH protocol |
Drop |
|
|
|
|
120 |
Patient smoked 100 cigarettes during life |
Drop |
|
|
|
|
121 |
Average daily cigarettes smoked |
Drop |
|
|
|
See Attachment C6 for Detailed Item Descriptions
See Attachment C6 for detailed justification of changes, including citations from scientific literature
See Attachment C8-b for Success Rate Calculations and methodology
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | lmf3 |
File Modified | 0000-00-00 |
File Created | 2021-01-25 |